<DOC>
	<DOC>NCT01816958</DOC>
	<brief_summary>application of external neuromodulation along with ketamine infusion.</brief_summary>
	<brief_title>Neuromodulation to Facilitate the Effect of Ketamine</brief_title>
	<detailed_description>apply TMS concurrent with ketamine infusion in order to increase the likliehood &amp; strength of therapeutic benefit</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>chronically ill, treatmentresistant active psychosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>thalamocortical dysrhythmia</keyword>
	<keyword>transcranial magnetic stimulation (TMS)</keyword>
	<keyword>transcranial Electrical Stimulation (tES)</keyword>
	<keyword>(N-methyl-D-aspartate) NMDA-R antagonist</keyword>
	<keyword>ketamine infusion</keyword>
	<keyword>neuromodulation</keyword>
	<keyword>synergistic effect</keyword>
	<keyword>remission</keyword>
</DOC>